glp 1 agonists for alcohol use disorder GLP1 receptor may reduce addictive behaviors | JAMA Psychiatry posted on the topic IUPHAR review – Glucagon-like peptide-1

Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model

As of March 2026, nearly 8 out of every 100 prescriptions were for GLP-1 RAs

In some videos, though, the results look pretty spectacular

It enhances absorption and stability of the semaglutide molecule

Front Immunol (2022) 13:772446

Results: When LC was assessed as quartiles, compared with patients with low LC (Q1), patients in the highest quartile (Q4) had a 33% (OR = 0.67, 95% CI: 0.46 to 0.99), 52% (OR = 0.48, 95% CI: 0.23 to 0.99), and 39% (OR = 0.61, 95% CI: 0.38 to 0.99) decreased risk of overall, digestive system, and non-digestive system cancer in the adjusted models, respectively